Bio-Rad director exercises RSUs, receives new grant

Bio-Rad Laboratories director Jeffrey L. Edwards exercised restricted stock units into Bio-Rad Class A common shares and received a new equity award.

Rhea-AI Filing Summary

Bio-Rad Laboratories director Jeffrey L. Edwards exercised restricted stock units into Bio-Rad Class A common shares and received a new equity award. He acquired 407 shares of Bio-Rad A Common Stock upon vesting of restricted stock units, bringing his direct holdings to 715 shares.

At the same time, 407 Restricted Stock Units were fully converted, leaving no remaining units from that grant. Edwards was also granted 369 new Restricted Stock Units, each representing a contingent right to receive one share of Bio-Rad Class A common stock, vesting 100% on the earlier of the first anniversary of the grant date or the company’s next annual meeting of stockholders.

Insider Trade Summary

407 shares exercised/converted

Exercise 3 txns

Insider EDWARDS JEFFREY L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	369	$0.00	$0.00
Exercise	Restricted Stock Units	407	$0.00	$0.00
Exercise	Bio-Rad A Common Stock	407	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 369 contracts (Direct); Bio-Rad A Common Stock — 715 shares (Direct)

Footnotes (3)

1. F1. Shares of Class A common stock acquired on the vesting of restricted stock units.
2. F2. Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
3. F3. The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders.

Key Figures

RSUs exercised: 407 shares Shares held after: 715 shares New RSU grant: 369 units +1 more

4 metrics

RSUs exercised 407 shares Restricted Stock Units converted into Bio-Rad A Common Stock

Shares held after 715 shares Bio-Rad A Common Stock held directly after transactions

New RSU grant 369 units New Restricted Stock Units awarded to director

RSU-to-share ratio 1:1 Each RSU represents one share of Class A common stock

Key Terms

Restricted Stock Units, vest 100%, contingent right

3 terms

Restricted Stock Units financial

"The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vest 100% financial

"The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders."

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity transactions did BIO director Jeffrey L. Edwards report?

Jeffrey L. Edwards reported the vesting and exercise of 407 restricted stock units into Bio-Rad Class A common shares and the grant of 369 new restricted stock units. These are compensation-related equity movements, not open-market stock purchases or sales.

How many Bio-Rad (BIO) shares does Jeffrey L. Edwards hold after this Form 4?

After these transactions, Jeffrey L. Edwards directly holds 715 shares of Bio-Rad A Common Stock. This reflects the addition of 407 shares acquired upon vesting of restricted stock units, according to the reported total shares following the transaction.

How many restricted stock units were exercised and granted in this Bio-Rad (BIO) filing?

Edwards exercised 407 Restricted Stock Units into an equal number of Bio-Rad Class A common shares, reducing that RSU position to zero. He also received a new grant of 369 Restricted Stock Units as an additional equity award linked to future vesting.

What does each restricted stock unit represent for Bio-Rad (BIO) director Jeffrey L. Edwards?

Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. This means the units convert into actual shares only upon satisfying vesting conditions outlined in the award terms.

When will Jeffrey L. Edwards’ new Bio-Rad (BIO) restricted stock units vest?

The new restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of Bio-Rad’s next annual meeting of stockholders. Full vesting must occur on one of these specified milestones.

Did Jeffrey L. Edwards sell any Bio-Rad (BIO) shares in this Form 4 filing?

The filing does not report any open-market sales. It shows an exercise of 407 restricted stock units into Bio-Rad A Common Stock and a grant of 369 new restricted stock units, with no sale transactions coded or described.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/23/2026 - 03:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

EDWARDS JEFFREY L

(Last) (First) (Middle)

C/O BIO-RAD LABORATORIES, INC.

1000 ALFRED NOBEL DRIVE

(Street)

HERCULES CALIFORNIA 94547

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BIO-RAD LABORATORIES, INC. [ BIO BIO.B ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Bio-Rad A Common Stock	04/21/2026		M		407(1)	A	$0	715	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(2)	04/21/2026		A		369		(3)	(3)	Bio-Rad A Common Stock	369	$0	369	D
Restricted Stock Units	$0(2)	04/21/2026		M			407	(3)	(3)	Bio-Rad A Common Stock	407	$0	0	D

Explanation of Responses:

1. Shares of Class A common stock acquired on the vesting of restricted stock units.

2. Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

3. The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders.

Remarks:

	/s/ Jeffrey L. Edwards	04/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)